🚨 Check out our latest article on the multi-disciplinary management of brain metastases published in NatureRevClinOncol 🚨 Huge team effort, laying out the latest developments while also highlighting how much gap still exists in the literature. go.nature.com/41GQt5W

⚡️ New multicenter data on SBRT for primary renal cell carcinoma (RCC): - 98% LC at 1 year, 96% at 5 years - Median OS: 58 months - Preserved renal function & low severe toxicity A promising noninvasive option for inoperable RCC #KidneyCancer #Oncology Shankar Siva

Hey, what do you think? IV or IO? This video in our partnership with Dr. Glaucomflecken summarizes new research comparing initial attempts at intraosseous or intravenous vascular access in adults who had out-of-hospital cardiac arrest. Full trial: nej.md/DrG14

REPRESENTATION MATTERS! Study finds that members of NCCN committees include: 48%- med onc 21%- surg onc 9%- rad onc (3% Chair; 23% VC) Emphasizes opportunity for growth as specialty inclusivity is critical to balance diversity of perspectives in management recommendations

Can A-RT be an effective strategy in technically resectable but medically inoperable PDAC? New study from Memorial Sloan Kettering Cancer Center suggests it might. Key findings: •25 pts with resectable PDAC, ineligible for surgery (medical comorbs), received ablative RT (100-Gy BED) •2-year local

1) After two years of mentoring UBC student Aiden under the supervision of Rob Olson and Sarah Baker at BC Cancer, our project is finally out in IJROBP - The Red Journal ! redjournal.org/article/S0360-…

Many of us have spent years focused on training and financial literacy often becomes an afterthought. Register today for the first webinar on 4/29 of a 3 part “Financial Principles for Rad Onc’s” bootcamp series! In collab with ASTRO ACRO - American College of Radiation Oncology Amer. Radium Society

In toxic cultures, burnout is a badge of honor. Working through exhaustion is celebrated. In hustle cultures, burnout is a sign of weakness. Hiding exhaustion is rewarded. In healthy cultures, burnout is a call for help. Exhaustion highlights a workload problem to be solved.

Stacy Loeb, MD Andrew Vickers Absolutely! Percentage and volume of pattern 4 in 3+4 is also the best tool for select for appropriate GG2 AS candidates

Exciting to do the first case @pennstatehershey with the new Espirit gamma knife stereotactic radiosurgery system. This new system offers greater patient comfort and increased precision in radiation delivery. @pennstneurosurg @elekta_ #brain #brainmets #glioma #braintumor

Congrats Tim Brown, MD MSCE! In this retrospective study, the addition of RT to atezo/bev added no measurable toxicity & was associated w improved RR (73% v 18%) & median OS (14.4 v 10.8 mo). Look forward to NRG GI-012, a Ph III trial assessing IO +/- SBRT for advanced HCC w MVI.

The reason our profession still has a soul. "...There’s no CPT code for staring at the ceiling at 3:17 AM. No RVU for rethinking a plan you already wrote down, but now feel could be better. No checkbox for “heart still engaged, even off the clock.” And yet… this is medicine.

Surprising data from Sunnybrook Dr. Andrew Loblaw for higher BCR with HDR mono vs sbrt - controversy enough to crash the slides.

Giulio Francolini Vedang Murthy Dr Gillessen assuring us we mostly agree - selection of systemic intensification critical and notes we have mult studies soon reporting to answer qs w data over dogma. Shortening ADT via ARPI intensification also appealing idea.

EMBRACE II: New standard of care for locally advanced cervical cancer! 📌 Advanced RT technology. 📌 Image-guided adaptive brachytherapy. 📌 Limited overall treatment time. 📌 Excellent disease control and overall survival. 📌 Low late severe morbidity. #ESTRO2025

X-torial: Cleaning up the misinformation about Joe Biden and #ProstateCancer that I am reading everywhere. The purpose of this is to provide education from someone who treats and studies PCa for a living, lead the USA National Comprehensive Cancer Network (NCCN) PCa guidelines, hold leadership in NRG Oncology National Cancer Institute

PSMA PET: A highly specific tool in initial staging of prostate cancer. Yet sensitivity remains modest. The challenge? Detecting nodal disease—not missing it. #ASCO25 #cancer #oncology OncoAlert ASCO Kate Sears Toni Choueiri, MD Emre Yekedüz Neeraj Agarwal, MD, FASCO 𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

Such a well deserved standing ovation for Chris Booth and the Challenge trial. These data are quite powerful. Much stronger evidence than what we saw in plenaries today. #ASCO25

Despite RP + RT patients generally younger/healthier than RT patients (and very outdated RT), this observational non-randomized study shows RP+RT have highest risk of urinary adverse events. Important counseling for high risk PCa given trials consistently demonstrate ~80% will

So you've heard the practice changing exercise CHALLENGE trial! But what did that groundbreaking exercise program actually look like day-to-day? Let's explore the "Structured Exercise Program" based on info from their paper supplement on NEJM #ASCO2025 #ASCO25 1/10